INS and obesity disorder: In primary hepatocytes, we found that classical antidiabetic and insulin-sensitizer drugs, e.g., metformin and rosiglitazone, as well as micronutrients known to improve metabolism and obesity, e.g., the isoflavone genistein, specifically modulate the expression of these hepatokines.